Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
PRGO [NYSE]
Perrigo Co.
IndexS&P 500 P/E16.51 EPS (ttm)8.60 Insider Own0.20% Shs Outstand133.75M Perf Week-1.57%
Market Cap18.99B Forward P/E17.67 EPS next Y8.03 Insider Trans-53.84% Shs Float133.04M Perf Month-14.55%
Income832.40M PEG1.25 EPS next Q1.52 Inst Own45.50% Short Float1.73% Perf Quarter-9.60%
Sales3.80B P/S5.00 EPS this Y12.00% Inst Trans0.03% Short Ratio2.04 Perf Half Y7.76%
Book/sh86.12 P/B1.65 EPS next Y21.25% ROA11.50% Target Price174.79 Perf Year20.98%
Cash/sh4.54 P/C31.31 EPS next 5Y13.22% ROE21.40% 52W Range111.82 - 168.39 Perf YTD-7.41%
Dividend0.42 P/FCF51.75 EPS past 5Y26.20% ROI11.90% 52W High-15.68% Beta0.35
Dividend %0.30% Quick Ratio1.60 Sales past 5Y15.40% Gross Margin52.10% 52W Low26.98% ATR4.17
Employees9900 Current Ratio2.40 Sales Q/Q10.90% Oper. Margin32.50% RSI (14)34.98 Volatility2.92% 2.90%
OptionableYes Debt/Eq0.39 EPS Q/Q-177.70% Profit Margin21.90% Rel Volume0.75 Prev Close143.32
ShortableYes LT Debt/Eq0.37 EarningsMay 07 BMO Payout4.20% Avg Volume1.13M Price141.99
Recom1.80 SMA20-6.13% SMA50-9.09% SMA200-0.22% Volume842,652 Change-0.93%
03-Mar-14Reiterated UBS Buy $176 → $190
03-Mar-14Reiterated Stifel Buy $165 → $175
25-Feb-14Reiterated CRT Capital Buy $165 → $175
07-Feb-14Downgrade B. Riley & Co. Buy → Neutral
16-Jan-14Reiterated Argus Buy $160 → $175
07-Jan-14Initiated RBC Capital Mkts Top Pick $187
12-Dec-13Reiterated Stifel Buy $150 → $165
07-Nov-13Reiterated Argus Buy $152 → $160
04-Nov-13Reiterated UBS Buy $140 → $160
21-Oct-13Initiated Argus Buy $152
17-Sep-13Initiated CRT Capital Buy $145
30-Jul-13Reiterated B. Riley & Co. Buy $139 → $145
09-Jul-13Reiterated Canaccord Genuity Buy $128 → $140
25-Feb-13Upgrade UBS Neutral → Buy $115 → $130
12-Feb-13Reiterated Deutsche Bank Hold $110 → $115
04-Feb-13Upgrade Canaccord Genuity Hold → Buy $128
04-Feb-13Reiterated RBC Capital Mkts Sector Perform $109 → $111
28-Jan-13Initiated RBC Capital Mkts Sector Perform $109
08-Nov-12Downgrade Caris & Company Buy → Above Average $136 → $129
05-Nov-12Upgrade Barrington Research Mkt Perform → Outperform $142
10-Apr-14 05:03PM  SAC Record $1.8 Billion Insider Plea Caps 7-Year Probe Bloomberg
01:46PM  SAC Record $1.8 Billion Insider Plea Caps 7-Year Probe Bloomberg
01:43PM  Perrigo Company (PRGO) Showing Signs Of Being A Roof Leaker at TheStreet
12:27AM  Buy Actavis - An Attractive Value And Growth Play That Is Also A Top Guru Fund Pick at Seeking Alpha
09-Apr-14 02:32PM  Can Perrigo Company PLC Continue Its Bull Run? at Motley Fool
07-Apr-14 02:09PM  Sun Pharmaceutical agrees to acquire generic drugmaker Ranbaxy at theflyonthewall.com
01:07PM  [video] Diversifying your pharma portfolio at CNBC
09:41AM  $5.6 Billion Questcor Deal Means High Drug Prices For Everybody at Forbes
04-Apr-14 05:28PM  Mylan Bid Gets Rejected, But Generic-Drugmaker Rises at Investor's Business Daily
10:30AM  Mylan to Buy Swedish Company? Zacks
01-Apr-14 08:16AM  Perrigo Announces Launch Of Authorized Generic Version Of Taclonex® Ointment (Calcipotriene 0.005% / Betamethasone Dipropionate 0.064%) PR Newswire
28-Mar-14 09:00AM  Davidson Kempner opens a new 4Q13 position in Lamar Advertising Market Realist
27-Mar-14 05:30PM  Perrigo Inks Deal Zacks
04:37PM  Davidson Kempner Capital buys a new position in Perrigo in 4Q13 Market Realist
26-Mar-14 09:48AM  Perrigo partners with KanPak to manufacture store brand Ensure at theflyonthewall.com
09:40AM  Perrigo Partners With Division Of Golden State Foods To Manufacture Store Brand Versions Of Ensure® Adult Nutritional Drinks PR Newswire
08:45AM  J.P. Morgan Says Buy Specialty and Big Pharmaceuticals Now at 24/7 Wall St.
25-Mar-14 05:00PM  Israel Englanders Millennium Management ups its stake in Perrigo Market Realist
01:00PM  Millennium Management buys a new position in SunTrust Banks Market Realist
20-Mar-14 06:21PM  Fund Strategists See Rosy Prognosis For Biotechs Stocks Like Biogen at Investor's Business Daily
19-Mar-14 10:45AM  Horizon Pharma To Buy Vidara, Join Exodus To Ireland at Investor's Business Daily
10:30AM  Horizon Inks $660M Reverse Merger With Ireland's Vidara at Fox Business
12-Mar-14 08:43AM  Perrigo Announces Launch Of Generic Version Of Neptazane (Methazolamide) Tablets PR Newswire
06-Mar-14 11:50AM  Perrigo Continues to Expand Zacks
11:50AM  Perrigo Continues to Expand
04-Mar-14 06:00PM  [video] Bought, not sold on Monday's pullback: Cramer at CNBC
06:00PM  [video] Bought, not sold on Monday's pullback: Cramer
28-Feb-14 07:17AM  Perrigo transfers development of ELND005 to Transition Therapeutics at theflyonthewall.com
07:17AM  Perrigo transfers development of ELND005 to Transition Therapeutics
07:13AM  Perrigo Company plc Announces The Transfer Of Development Asset ELND005 To Transition Therapeutics Inc. PR Newswire
07:13AM  Perrigo Company plc Announces Acquisition Of OTC Products In Australia PR Newswire
27-Feb-14 07:14AM  Cramer's 7 major investment themes built to last at CNBC
07:14AM  Cramer's 7 major investment themes built to last
25-Feb-14 12:00PM  Insider Trading Alert - KEX, XEC And PRGO Traded By Insiders at TheStreet
11:14AM  Perrigo Company (PRGO) Is Today's Unusual Social Activity Stock at TheStreet
11:14AM  Perrigo Company (PRGO) Is Today's Unusual Social Activity Stock
19-Feb-14 10:57AM  Perrigo Company plc To Present At Upcoming Healthcare Conference PR Newswire
07-Feb-14 11:36AM  What Does Martoma's Conviction Mean For SAC Capital's Steven Cohen? at Forbes
09:03AM  Perrigo downgraded by B. Riley & Co. Briefing.com
06-Feb-14 06:30PM  Perrigo Management Discusses Q2 2014 Results - Earnings Call Transcript at Seeking Alpha
06:16PM  Questions Remain After SAC Capital's Mathew Martoma Is Found Guilty at BusinessWeek
04:16PM  Stocks Close Broadly Higher But Volume Declines at Investor's Business Daily
02:24PM  Ex-SAC Fund Manager Martoma Found Guilty in Insider Case at Bloomberg
01:24PM  Perrigo posts 2Q loss on Elan-related costs AP
01:09PM  Earnings Beat at Perrigo, Guides Up Zacks
09:55AM  [video] Cramer's Six in 60: FUEL, FIVE, NYT & more at CNBC
08:37AM  [$$] Perrigo Swings to Loss on Acquisition Expenses at The Wall Street Journal
08:03AM  Perrigo Company plc Reports Record Revenue, Adjusted Earnings and Margins PR Newswire
07:07AM  Q2 2014 Perrigo Company Earnings Release - Before Market Open CCBN
05-Feb-14 03:00PM  SAC Capital Insider Jury Seeks Testimony Favoring Defense at Bloomberg
04-Feb-14 12:50PM  Is Perrigo (PRGO) Poised to Beat Earnings Estimates? Zacks
31-Jan-14 06:01PM  Cramer's game plan: Scoping out opportunity in week ahead at CNBC
06:01PM  Cramer's game plan: Scoping out opportunity in week ahead
06:00PM  [video] Employment number could tamper market: Cramer at CNBC
06:00PM  [video] Employment number could tamper market: Cramer
30-Jan-14 04:39PM  Pharma Rollups In Midst Of A Bubble That Might Be About To Burst at Seeking Alpha
01:30PM  A Novel Insider-Trading Defense? Any Defense at All at BusinessWeek
01:30PM  A Novel Insider-Trading Defense? Any Defense at All
29-Jan-14 11:20AM  Perrigo Company plc Announces Quarterly Dividend PR Newswire
11:20AM  Perrigo Company plc Announces Quarterly Dividend
24-Jan-14 07:50AM  Perrigo Receives FDA Final Approval For Generic Equivalent To Prandin® PR Newswire
07:50AM  Perrigo Receives FDA Final Approval For Generic Equivalent To Prandin®
23-Jan-14 09:41AM  Perrigo Company plc to Release Second Quarter Fiscal Year 2014 Results on February 6, 2014 PR Newswire
09:41AM  Perrigo Company plc to Release Second Quarter Fiscal Year 2014 Results on February 6, 2014
21-Jan-14 04:41PM  Perrigo Company Now #202 Largest Company, Surpassing Macy's at TheStreet
04:41PM  Perrigo Company Now #202 Largest Company, Surpassing Macy's
17-Jan-14 10:30AM  Generic Unit at Perrigo Looks Promising Zacks
10:30AM  Generic Unit at Perrigo Looks Promising
08:21AM  Concerns on Perrigo overdone, says RBC Capital at theflyonthewall.com
08:21AM  Concerns on Perrigo overdone, says RBC Capital
15-Jan-14 06:42PM  Drug Buyouts On The Rise -- But Buyers Changing at Investor's Business Daily
06:42PM  Drug Buyouts On The Rise But Buyers Changing at Investor's Business Daily
06:42PM  Drug Buyouts On The Rise -- But Buyers Changing
05:07PM  Allergan Wont Seek Further Foothold in Ireland, CEO Pyott Says at Bloomberg
05:07PM  Allergan Wont Seek Further Foothold in Ireland, CEO Pyott Says
08:05AM  Biogen, Celgene Lead 5 Top Large-Cap Drugmakers at Investor's Business Daily
14-Jan-14 02:57PM  Perrigo Announces FDA Final Approval for Generic Version of Vanos® (Fluocinonide) Cream 0.1% PR Newswire
02:57PM  Perrigo Announces FDA Final Approval for Generic Version of Vanos® (Fluocinonide) Cream 0.1%
13-Jan-14 02:28PM  Perrigo CEO says Elan gives 'gateway' to Europe, will lower tax rate at theflyonthewall.com
02:28PM  Perrigo CEO says Elan gives 'gateway' to Europe, will lower tax rate
02:24PM  [video] Perrigo CEO: Got to get our name out at CNBC
02:24PM  [video] Perrigo CEO: Got to get our name out
02:24PM  [video] Perrigo CEO: Elan purchase lowers tax rate at CNBC
02:24PM  [video] Perrigo CEO: Elan purchase lowers tax rate
12-Jan-14 07:00PM  Buying Discount Baby Formula? Another Win for Perrigo! at Motley Fool
07:00PM  Buying Discount Baby Formula? Another Win for Perrigo!
11-Jan-14 05:00PM  Perrigo at Record on M&A Outlook Amid Tax Rate: Israel Overnight at Bloomberg
05:00PM  Perrigo at Record on M&A Outlook Amid Tax Rate: Israel Overnight
10-Jan-14 05:40PM  [$$] SAC Insider Trial Could Hinge on Doctor Testimony at The Wall Street Journal
12:46AM  Are Generic Drug Stocks The Cure For A Hung-Over Health Care Market? at Seeking Alpha
08-Jan-14 04:26PM  Perrigo Company plc To Host Investor Day And To Present At The 32nd Annual J.P. Morgan Healthcare Conference PR Newswire
04:26PM  Perrigo Company plc To Host Investor Day And To Present At The 32nd Annual J.P. Morgan Healthcare Conference
04:23PM  Stock Market Closes Mixed; More Medicals Break Out at Investor's Business Daily
04:23PM  Stock Market Closes Mixed; More Medicals Break Out
07-Jan-14 06:16PM  The S&P 500's 5 Most Loved Stocks at Motley Fool
06:16PM  The S&P 500's 5 Most Loved Stocks
03:21PM  Notice of Allowance Received by Alkermes Zacks
03:21PM  Notice of Allowance Received by Alkermes
09:55AM  [video] Cramer's Six in 60: MGM, PCLN & more at CNBC
09:55AM  [video] Cramer's Six in 60: MGM, PCLN & more
Perrigo Company Public Limited Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API) primarily in the United States, Israel, the United Kingdom, Mexico, and Australia. Its Consumer Healthcare business offers various OTC and nutrition products, including analgesics, cough and cold remedies, and gastrointestinal and feminine hygiene products, as well as vitamins, dietary supplements, and nutritional drinks. The company's Nutritionals business develops, manufactures, markets, and distributes infant formula, pediatric nutritionals and vitamins, minerals, and supplements primarily under the Centrum, One-A-Day, Flintstones, and Osteo-Bi-Flex brands. Its Rx Pharmaceuticals business develops, manufactures, and markets a portfolio of generic prescription drugs in topical dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, and powders, as well as controlled substances, injectables, hormones, and oral liquids and oral solid dosage forms. The company's Active Pharmaceutical Ingredients (API) business develops, manufactures, and markets differentiated APIs and finished dosage forms for the branded and generic pharmaceutical industries. In addition, Perrigo Company Public Limited Company is developing TYSABRI for the treatment of multiple sclerosis and crohn's disease; and ELND005 for the treatment of Alzheimer's disease and bipolar disorder. Its Pharmaceutical and Medical Diagnostic Products business markets and manufactures branded prescription drugs under licenses; and imports other pharmaceutical and medical diagnostic products. The company sells its products to drug stores, wholesalers, distributors, hospital systems, and group purchasing organizations. Perrigo Company Public Limited Company was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PAPA JOSEPH CPresident and CEODec 12Option Exercise48.5615,000728,401125,506Dec 16 04:30 PM
PAPA JOSEPH CPresident and CEODec 12Sale150.1215,0002,251,819116,655Dec 16 04:30 PM
COHEN GARY MDirectorDec 12Sale152.524,632706,47311,868Dec 16 04:27 PM
JANDERNOA MICHAEL JDirectorDec 09Sale154.9768,62010,634,213120,552Dec 10 03:54 PM
JANDERNOA MICHAEL JDirectorDec 06Sale155.6760,0009,339,918148,000Dec 10 03:54 PM
Yu LouisExecutive VP Global QualityDec 05Sale155.227010,8655,420Dec 09 03:06 PM
Yu LouisExecutive VP Global QualityNov 25Sale155.512,292356,4228,548Nov 26 02:47 PM
KINGMA TODD WExecutive VP, General CounselNov 22Sale154.976,5001,007,3123,000Nov 26 02:48 PM
Brown Judy LExecutive VP & CFONov 21Sale154.749,9881,545,5630Nov 22 02:47 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyNov 20Sale152.808,4001,283,5440Nov 22 02:38 PM
Kochan SharonExecutive VP U.S. GenericsNov 15Sale152.5345569,4015,086Nov 19 02:54 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyNov 12Option Exercise90.654,518409,5572,259Nov 14 02:45 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyNov 12Sale150.004,518677,7000Nov 14 02:45 PM
JANDERNOA MICHAEL JDirectorNov 07Sale144.34755108,973868Nov 12 06:30 PM
Gottfried RanDirectorNov 04Option Exercise89.422,275203,43113,884Nov 06 10:27 AM
Gottfried RanDirectorNov 04Sale143.362,275326,15111,609Nov 06 10:27 AM
Brown Judy LExecutive VP & CFOOct 01Option Exercise30.061,41642,56518,849Oct 02 04:13 PM
Brown Judy LExecutive VP & CFOOct 01Sale123.421,416174,76217,433Oct 02 04:13 PM
PAPA JOSEPH CPresident and CEOSep 24Option Exercise35.8515,000537,750131,655Sep 26 10:11 AM
PAPA JOSEPH CPresident and CEOSep 24Sale124.6015,0001,869,015116,655Sep 26 10:11 AM
HENDRICKSON JOHN TEVP Global Operations & SupplySep 18Option Exercise58.822,161127,1102,161Sep 19 05:08 PM
HENDRICKSON JOHN TEVP Global Operations & SupplySep 18Sale125.002,161270,1250Sep 19 05:08 PM
Stewart Michael RobertSr. VP Global Human ResourcesSep 11Option Exercise86.873,208278,6741,121Sep 13 03:40 PM
Stewart Michael RobertSr. VP Global Human ResourcesSep 11Sale123.375,063624,6360Sep 13 03:40 PM
Yu LouisExecutive VP Global QualitySep 09Option Exercise58.821,852108,93512,692Sep 11 03:36 PM
Yu LouisExecutive VP Global QualitySep 09Sale124.111,852229,85210,840Sep 11 03:36 PM
HENDRICKSON JOHN TEVP Global Operations & SupplySep 06Sale123.461,000123,45518,279Sep 10 03:56 PM
HENDRICKSON JOHN TEVP Global Operations & SupplySep 04Sale123.922,000247,83120,279Sep 06 10:42 AM
Brown Judy LExecutive VP & CFOSep 03Option Exercise30.062,50075,15019,933Sep 05 01:22 PM
Jamison Scott FExecutive Vice President PBMSep 03Sale122.1278095,2542,799Sep 05 01:24 PM
Brown Judy LExecutive VP & CFOSep 03Sale122.072,500305,16717,433Sep 05 01:22 PM
Needham JeffreySr. VP Commercial Business DevAug 30Option Exercise76.083,613274,8727,158Sep 04 12:22 PM
Needham JeffreySr. VP Commercial Business DevAug 30Sale120.476,585793,2955,199Sep 04 12:22 PM
Kochan SharonExecutive VP U.S. GenericsAug 29Option Exercise58.821,32377,8196,864Sep 03 01:21 PM
Kochan SharonExecutive VP U.S. GenericsAug 29Sale120.983,467419,4435,541Sep 03 01:21 PM
PAPA JOSEPH CPresident and CEOAug 27Option Exercise35.8515,000537,750133,455Aug 29 02:37 PM
PAPA JOSEPH CPresident and CEOAug 27Sale117.6415,0001,764,590118,455Aug 29 02:37 PM
Brown Judy LExecutive VP & CFOAug 26Sale119.283,424408,40717,433Aug 27 04:01 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyAug 26Sale119.152,099250,1030Aug 27 04:02 PM
Farrington ThomasSenior VP and CIOAug 26Sale119.30937111,7841,040Aug 27 04:03 PM
KINGMA TODD WExecutive VP, General CounselAug 20Sale118.622,808333,09717,065Aug 21 04:55 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyAug 20Sale118.561,676198,7030Aug 21 04:53 PM
Farrington ThomasSenior VP and CIOAug 20Sale119.4073287,4011,040Aug 21 04:52 PM
Brown Judy LExecutive VP & CFOAug 20Sale118.582,804332,48517,433Aug 21 04:51 PM
Farrington ThomasSenior VP and CIOAug 19Option Exercise90.961,997181,6382,698Aug 21 04:52 PM
Brown Judy LExecutive VP & CFOAug 19Option Exercise118.744,973590,49422,406Aug 21 04:51 PM
Yu LouisSenior VP Global QualityAug 19Option Exercise118.741,071127,17110,242Aug 21 05:03 PM
Stewart Michael RobertSr. VP Global Human ResourcesAug 19Option Exercise118.741,173139,2821,173Aug 21 05:02 PM
Shah JatinSr VP & Chief Scientific OfficAug 19Option Exercise118.741,275151,3943,617Aug 21 05:01 PM
PAPA JOSEPH CPresident and CEOAug 19Option Exercise118.7415,0461,786,562115,046Aug 21 05:00 PM
Needham JeffreySr. VP Commercial Business DevAug 19Option Exercise118.741,913227,1507,101Aug 21 04:59 PM
Kochan SharonExecutive VP U.S. GenericsAug 19Option Exercise118.741,530181,6727,022Aug 21 04:58 PM
KINGMA TODD WExecutive VP, General CounselAug 19Option Exercise118.744,106487,54621,171Aug 21 04:55 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyAug 19Option Exercise118.742,499296,7312,499Aug 21 04:53 PM
Farrington ThomasSenior VP and CIOAug 19Sale120.22926111,3241,772Aug 21 04:52 PM
KINGMA TODD WExecutive VP, General CounselAug 16Option Exercise35.851,25044,81318,315Aug 20 01:53 PM
KINGMA TODD WExecutive VP, General CounselAug 16Sale120.001,250150,00017,065Aug 20 01:53 PM
KINGMA TODD WExecutive VP, General CounselJul 19Option Exercise35.851,25044,81318,315Jul 23 08:32 AM
KINGMA TODD WExecutive VP, General CounselJul 19Sale129.371,250161,71317,065Jul 23 08:32 AM
PAPA JOSEPH CPresident and CEOJul 11Option Exercise35.8510,000358,500110,000Jul 15 03:18 PM
PAPA JOSEPH CPresident and CEOJul 11Sale128.5410,0001,285,355100,000Jul 15 03:18 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyJul 09Option Exercise58.822,161127,1102,161Jul 11 02:27 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyJul 09Sale125.002,161270,1250Jul 11 02:27 PM
KINGMA TODD WExecutive VP, General CounselJun 14Option Exercise35.851,25044,81318,315Jun 18 10:47 AM
PAPA JOSEPH CPresident and CEOJun 14Option Exercise35.8510,000358,500110,000Jun 18 10:49 AM
PAPA JOSEPH CPresident and CEOJun 14Sale118.3910,0001,183,910100,000Jun 18 10:49 AM
KINGMA TODD WExecutive VP, General CounselJun 14Sale118.001,250147,50017,065Jun 18 10:47 AM
Brown Judy LExecutive VP & CFOJun 04Option Exercise30.062,50075,15019,933Jun 06 02:31 PM
Brown Judy LExecutive VP & CFOJun 04Sale116.382,500290,95017,433Jun 06 02:31 PM
Shah JatinSr VP & Chief Scientific OfficMay 17Option Exercise15.473,12048,2663,520May 21 03:19 PM
Shah JatinSr VP & Chief Scientific OfficMay 17Sale119.602,268271,2601,900May 21 03:19 PM
KINGMA TODD WExecutive VP, General CounselMay 16Sale120.211,400168,29817,065May 20 08:40 AM
PAPA JOSEPH CPresident and CEOMay 15Option Exercise35.855,000179,250105,000May 17 12:12 PM
PAPA JOSEPH CPresident and CEOMay 15Sale120.515,000602,567100,000May 17 12:12 PM
Kochan SharonExecutive VP U.S. GenericsMay 14Option Exercise58.822,647155,6978,139May 16 03:02 PM
Kochan SharonExecutive VP U.S. GenericsMay 14Option Exercise58.822,647155,6978,139Aug 21 04:57 PM
Kochan SharonExecutive VP U.S. GenericsMay 14Sale119.642,647316,6875,492Aug 21 04:57 PM
Shah JatinSr VP & Chief Scientific OfficMay 14Sale119.773,672439,7851,490May 16 03:06 PM
Kochan SharonExecutive VP U.S. GenericsMay 14Sale119.642,647316,6875,492May 16 03:02 PM
Gottfried RanDirectorMay 13Option Exercise59.742,224132,86213,833May 15 10:16 AM
Stewart Michael RobertSr. VP Global Human ResourcesMay 13Option Exercise20.501,56031,9801,560May 15 10:17 AM
Stewart Michael RobertSr. VP Global Human ResourcesMay 13Sale119.684,092489,7210May 15 10:17 AM
Gottfried RanDirectorMay 13Sale119.532,224265,84311,609May 15 10:16 AM
Brown Judy LExecutive VP & CFOMay 07Option Exercise30.062,50075,15019,933May 09 10:23 AM
Brown Judy LExecutive VP & CFOMay 07Sale116.862,500292,15017,433May 09 10:23 AM
KINGMA TODD WExecutive VP, General CounselMay 03Option Exercise35.851,25044,81319,715May 07 12:29 PM
KINGMA TODD WExecutive VP, General CounselMay 03Sale119.691,250149,61318,465May 07 12:29 PM